← Back to all trials
Recruiting
NCT07726082
Micro-choice-based Intervention for Multicausal Fatigue
Conditions: Multicausal Fatigue, Fatigue, Post COVID Condition, Long COVID Syndrome, Postviral Fatigue
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: No
Phase: NA
Enrollment: 24
Sponsor: University Hospital, Basel, Switzerland
Location: University Hospital Basel Basel
Summary
This proof-of-concept study aims to evaluate the feasibility, acceptability, and potential benefits of a novel multimodal approach: the micro-choice-based intervention.
Eligibility Criteria
Inclusion Criteria:
* Experiencing persistent fatigue with a significant impact on daily functioning (Chalder Fatigue- Scale bimodal ≥ 4)
Exclusion Criteria:
* Have insufficient proficiency in German to complete study-related questionnaires
* Lack the cognitive capacity to understand study procedures (e.g. due to dementia)
* Present with severe medical conditions that may interfere with participation (e.g., advanced organ failure, uncontrolled inflammatory or autoimmune diseases, or severe psychiatric disorders)
* Have active cancer or are currently undergoing cancer treatment
* Are deemed incompatible with group participation during the preparation phase, based on a team assessment. Reasons for exclusion based on group incompatibility include:
(-Need for a level of individual therapeutic support that exceeds what can be provided in a group setting; -Refusal to engage in group-based therapy; -Personality traits that are considered incompatible with group dynamics; -Failure to attend the mandatory preparatory webinar (no-show is considered a no-go); -Other significant reasons as determined by the therapeutic team)
Source: ClinicalTrials.gov (NCT07726082). StuddyBuddy aggregates publicly available trial information.